HER-2/neu peptide specificity in the recognition of HLA-A2 by natural killer cells

Cancer Immunol Immunother. 1999 Oct;48(7):401-10. doi: 10.1007/s002620050593.

Abstract

Although natural killer (NK) cells have been described as non-MHC-restricted, new evidence suggests that NK activity can be either up- or down-regulated after interaction with the peptide-MHC-class-I complex expressed on target cells. However, the epitope(s) recognized by NK cells have remained ill-defined. We investigated NK cell recognition of synthetic peptides representing a portion of a self-protein encoded by the HER-2/neu (HER-2) proto-oncogene and presented by HLA-A2. HER-2 nonapeptides C85, E89, and E75 were found partially to protect T2 targets from lysis by freshly isolated and interleukin-2(IL-2)-activated NK cells (either HLA-A2(+) or A2(-)). This inhibition was not solely due to changes in the level of HLA-A2 expression or conformation of serological HLA-A2 epitopes. Using single-amino-acid variants at position 1 (P1) of two HER-2 peptides, we observed that protection of targets was dependent on the sequence and the side-chain. These results suggest similarities in the mechanism of target recognition by NK and T cells. This information may be important for understanding the mechanisms of tumor escape from immunosurveillance and could help explain the aggressiveness of HER-2-overexpressing tumor cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cells, Cultured
  • Cytotoxicity Tests, Immunologic
  • Epitopes / immunology*
  • Flow Cytometry
  • HLA-A2 Antigen / immunology*
  • HLA-A2 Antigen / metabolism
  • Histocompatibility Antigens Class I / metabolism
  • Humans
  • Interleukin-2 / pharmacology
  • Killer Cells, Natural / cytology
  • Killer Cells, Natural / drug effects
  • Killer Cells, Natural / immunology*
  • Lymphocyte Activation / drug effects
  • Mutagenesis, Site-Directed
  • Peptide Fragments / chemical synthesis
  • Peptide Fragments / immunology
  • Peptide Fragments / pharmacology
  • Proto-Oncogene Mas
  • Receptor, ErbB-2 / genetics
  • Receptor, ErbB-2 / immunology*
  • Transfection

Substances

  • Epitopes
  • HLA-A2 Antigen
  • Histocompatibility Antigens Class I
  • Interleukin-2
  • MAS1 protein, human
  • Peptide Fragments
  • Proto-Oncogene Mas
  • Receptor, ErbB-2